EcoDrugPlus

Alpha Glucosidase

Ensembl ID : ENSSDUG00000009067
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSSDUG00000021271
Gene Symbol: LOC111230373
3 Cross references
202 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSSDUG00000002978
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSSDUG00000009430
Gene Symbol: AMY1C
4 Cross references
213 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSSDUG00000012734
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSSDUG00000005382
Gene Symbol: LOC111218784
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSSDUG00000013992
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSSDUG00000011258
Gene Symbol: LOC111226503
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSSDUG00000005676
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSSDUG00000004561
Gene Symbol: LOC111220996
3 Cross references
128 Possible Orthologues:

Antithrombin-Iii-Like

Ensembl ID : ENSSDUG00000015799
Gene Symbol: LOC111236199
3 Cross references
198 Possible Orthologues:

Apelin Receptor B-Like

Ensembl ID : ENSSDUG00000023212
Gene Symbol: LOC111229879
3 Cross references
171 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).